Small interfering RNA-mediated suppression of Ccl2 in Müller cells attenuates microglial recruitment and photoreceptor death following retinal degeneration

Journal of Neuroinflammation

Volumn 9, Issue , 2012, Pages

  Rutar, Matt ^a,b   Natoli, Riccardo ^a,c   Provis, Jan M ^a,b,c  

^a Biology and Environment   (Australia)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^c The Australian National University   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CALCIUM BINDING PROTEIN; ED1 PROTEIN; IONIZED CALCIUM BINDING ADAPTOR 1; MONOCYTE CHEMOTACTIC PROTEIN 1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ADULT ANIMAL; ANIMAL CELL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CELL COUNT; CELL DEATH; CELL INFILTRATION; CONTROLLED STUDY; FROZEN SECTION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIGHT EXPOSURE; MICROGLIA; MONOCYTE; MUELLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PHOTORECEPTOR CELL; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RAT; RETINA DEGENERATION;

EID: 84866272970     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-9-221     Document Type: Article

References (106)

1. Bauer J, Sminia T, Wouterlood FG, Dijkstra CD. Phagocytic activity of macrophages and microglial cells during the course of acute and chronic relapsing experimental autoimmune encephalomyelitis. J Neurosci Res 1994, 38:365-375. 10.1002/jnr.490380402, 7932870.
2. Gupta N, Brown KE, Milam AH. Activated microglia in human retinitis pigmentosa, late-onset retinal degeneration, and age-related macular degeneration. Exp Eye Res 2003, 76:463-471. 10.1016/S0014-4835(02)00332-9, 12634111.
3. Neumann H, Kotter MR, Franklin RJ. Debris clearance by microglia: an essential link between degeneration and regeneration. Brain 2009, 132:288-295. 2640215, 18567623.
4. Penfold PL, Liew SC, Madigan MC, Provis JM. Modulation of major histocompatibility complex class II expression in retinas with age-related macular degeneration. Invest Ophthalmol Vis Sci 1997, 38:2125-2133.
5. Penfold PL, Provis JM, Liew SC. Human retinal microglia express phenotypic characteristics in common with dendritic antigen-presenting cells. J Neuroimmunol 1993, 45:183-191. 10.1016/0165-5728(93)90179-3, 8392519.
6. Mattiace LA, Davies P, Dickson DW. Detection of HLA-DR on microglia in the human brain is a function of both clinical and technical factors. Am J Pathol 1990, 136:1101-1114. 1877424, 1693471.
7. Matsubara T, Pararajasegaram G, Wu GS, Rao NA. Retinal microglia differentially express phenotypic markers of antigen-presenting cells in vitro. Invest Ophthalmol Vis Sci 1999, 40:3186-3193.
8. Nakajima K, Kohsaka S. Microglia: neuroprotective and neurotrophic cells in the central nervous system. Curr Drug Targets Cardiovasc Haematol Disord 2004, 4:65-84. 10.2174/1568006043481284, 15032653.
9. Langmann T. Microglia activation in retinal degeneration. J Leukoc Biol 2007, 81:1345-1351. 10.1189/jlb.0207114, 17405851.
10. Kim SU, de Vellis J. Microglia in health and disease. J Neurosci Res 2005, 81:302-313. 10.1002/jnr.20562, 15954124.
11. Wirenfeldt M, Babcock AA, Vinters HV. Microglia - insights into immune system structure, function, and reactivity in the central nervous system. Histol Histopathol 2011, 26:519-530.
12. Ezzat MK, Hann CR, Vuk-Pavlovic S, Pulido JS. Immune cells in the human choroid. Br J Ophthalmol 2008, 92:976-980. 10.1136/bjo.2007.129742, 18577650.
13. Penfold PL, Killingsworth MC, Sarks SH. Senile macular degeneration. The involvement of giant cells in atrophy of the retinal pigment epithelium. Invest Ophthalmol Vis Sci 1986, 27:364-271.
14. Wong J, Madigan M, Billson F, Penfold P. Quantification of leukocyte common antigen (CD45) expression in macular degeneration. Invest Ophthalmol Vis Sci 2001, 42:S227.
15. Cherepanoff S, McMenamin P, Gillies MC, Kettle E, Sarks SH. Bruch's membrane and choroidal macrophages in early and advanced age-related macular degeneration. Br J Ophthalmol 2009, 94:918-925.
16. Lewis GP, Sethi CS, Carter KM, Charteris DG, Fisher SK. Microglial cell activation following retinal detachment: a comparison between species. Mol Vis 2005, 11:491-500.
17. Vrabec F. Activated human retinal microglia under pathological conditions. Albrecht Von Graefes Arch Klin Exp Ophthalmol 1975, 196:49-60.
18. Yuan L, Neufeld AH. Activated microglia in the human glaucomatous optic nerve head. J Neurosci Res 2001, 64:523-532. 10.1002/jnr.1104, 11391707.
19. Neufeld AH. Microglia in the optic nerve head and the region of parapapillary chorioretinal atrophy in glaucoma. Arch Ophthalmol 1999, 117:1050-1056. 10.1001/archopht.117.8.1050, 10448748.
20. Zeng HY, Green WR, Tso MO. Microglial activation in human diabetic retinopathy. Arch Ophthalmol 2008, 126:227-232. 10.1001/archophthalmol.2007.65, 18268214.
21. Yang LP, Zhu XA, Tso MO. A possible mechanism of microglia-photoreceptor crosstalk. Mol Vis 2007, 13:2048-2057.
22. Roque RS, Rosales AA, Jingjing L, Agarwal N, Al-Ubaidi MR. Retina-derived microglial cells induce photoreceptor cell death in vitro. Brain Res 1999, 836:110-119. 10.1016/S0006-8993(99)01625-X, 10415410.
23. Boje KM, Arora PK. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res 1992, 587:250-256. 10.1016/0006-8993(92)91004-X, 1381982.
24. Chao CC, Hu S, Ehrlich L, Peterson PK. Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-D-aspartate receptors. Brain Behav Immun 1995, 9:355-365. 10.1006/brbi.1995.1033, 8903852.
25. McGuire SO, Ling ZD, Lipton JW, Sortwell CE, Collier TJ, Carvey PM. Tumor necrosis factor alpha is toxic to embryonic mesencephalic dopamine neurons. Exp Neurol 2001, 169:219-230. 10.1006/exnr.2001.7688, 11358437.
26. Sawada M, Kondo N, Suzumura A, Marunouchi T. Production of tumor necrosis factor-alpha by microglia and astrocytes in culture. Brain Res 1989, 491:394-397. 10.1016/0006-8993(89)90078-4, 2765895.
27. Hanisch UK. Microglia as a source and target of cytokines. Glia 2002, 40:140-155. 10.1002/glia.10161, 12379902.
28. Ding AH, Nathan CF, Stuehr DJ. J Immunol 1988, 141:2407-2412.
29. Garden GA, Moller T. Microglia biology in health and disease. J Neuroimmune Pharmacol 2006, 1:127-137. 10.1007/s11481-006-9015-5, 18040779.
30. Kataoka K, Nishiguchi KM, Kaneko H, van Rooijen N, Kachi S, Terasaki H. The roles of vitreal macrophages and circulating leukocytes in retinal neovascularization. Invest Ophthalmol Vis Sci 2011, 14:1431-1438.
31. Hoppeler T, Hendrickson P, Dietrich C, Reme C. Morphology and time-course of defined photochemical lesions in the rabbit retina. Curr Eye Res 1988, 7:849-860. 10.3109/02713688808997242, 3180834.
32. Ni YQ, Xu GZ, Hu WZ, Shi L, Qin YW, Da CD. Neuroprotective effects of naloxone against light-induced photoreceptor degeneration through inhibiting retinal microglial activation. Invest Ophthalmol Vis Sci 2008, 49:2589-2598. 10.1167/iovs.07-1173, 18515588.
33. Chang CJ, Cherng CH, Liou WS, Liao CL. Minocycline partially inhibits caspase-3 activation and photoreceptor degeneration after photic injury. Ophthalmic Res 2005, 37:202-213. 10.1159/000086610, 15990464.
34. Ibrahim AS, El-Shishtawy MM, Pena A. Liou GI: genistein attenuates retinal inflammation associated with diabetes by targeting of microglial activation. Mol Vis 2010, 16:2033-2042. 2965567, 21042558.
35. Krady JK, Basu A, Allen CM, Xu Y, LaNoue KF, Gardner TW, Levison SW. Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes 2005, 54:1559-1565. 10.2337/diabetes.54.5.1559, 15855346.
36. Bosco A, Inman DM, Steele MR, Wu G, Soto I, Marsh-Armstrong N, Hubbard WC, Calkins DJ, Horner PJ, Vetter ML. Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2 J mouse model of glaucoma. Invest Ophthalmol Vis Sci 2008, 49:1437-1446. 10.1167/iovs.07-1337, 18385061.
37. Neufeld AH. Pharmacologic neuroprotection with an inhibitor of nitric oxide synthase for the treatment of glaucoma. Brain Res Bull 2004, 62:455-459. 10.1016/j.brainresbull.2003.07.005, 15036557.
38. Yang LP, Li Y, Zhu XA, Tso MO. Minocycline delayed photoreceptor death in rds mice through iNOS-dependent mechanism. Mol Vis 2007, 13:1073-1082. 2779141, 17653052.
39. Karlstetter M, Ebert S, Langmann T. Microglia in the healthy and degenerating retina: insights from novel mouse models. Immunobiol 2010, 215:685-691.
40. Luster AD. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 1998, 338:436-445. 10.1056/NEJM199802123380706, 9459648.
41. Oppenheim JJ, Zachariae CO, Mukaida N, Matsushima K. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol 1991, 9:617-648. 10.1146/annurev.iy.09.040191.003153, 1910690.
42. Bajetto A, Bonavia R, Barbero S, Schettini G. Characterization of chemokines and their receptors in the central nervous system: physiopathological implications. J Neurochem 2002, 82:1311-1329. 10.1046/j.1471-4159.2002.01091.x, 12354279.
43. Ransohoff RM, Glabinski A, Tani M. Chemokines in immune-mediated inflammation of the central nervous system. Cytokine Growth Factor Rev 1996, 7:35-46. 10.1016/1359-6101(96)00003-2, 8864353.
44. Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 2009, 29:313-326. 10.1089/jir.2008.0027, 2755091,2755091, 19441883.
45. Matsushima K, Larsen CG, DuBois GC, Oppenheim JJ. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med 1989, 169:1485-1490. 10.1084/jem.169.4.1485, 2189236, 2926331.
46. Yoshimura T, Robinson EA, Tanaka S, Appella E, Kuratsu J, Leonard EJ. Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants. J Exp Med 1989, 169:1449-1459. 10.1084/jem.169.4.1449, 2189237, 2926329.
47. Nakazawa T, Hisatomi T, Nakazawa C, Noda K, Maruyama K, She H, Matsubara A, Miyahara S, Nakao S, Yin Y, et al. Monocyte chemoattractant protein 1 mediates retinal detachment-induced photoreceptor apoptosis. Proc Natl Acad Sci USA 2007, 104:2425-2430. 10.1073/pnas.0608167104, 1892947, 17284607.
48. Prat E, Baron P, Meda L, Scarpini E, Galimberti D, Ardolino G, Catania A, Scarlato G. The human astrocytoma cell line U373MG produces monocyte chemotactic protein (MCP)-1 upon stimulation with beta-amyloid protein. Neurosci Lett 2000, 283:177-180. 10.1016/S0304-3940(00)00966-6, 10754216.
49. Johnstone M, Gearing AJ, Miller KM. A central role for astrocytes in the inflammatory response to beta-amyloid; chemokines, cytokines and reactive oxygen species are produced. J Neuroimmunol 1999, 93:182-193. 10.1016/S0165-5728(98)00226-4, 10378882.
50. Simpson JE, Newcombe J, Cuzner ML, Woodroofe MN. Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions. J Neuroimmunol 1998, 84:238-249. 10.1016/S0165-5728(97)00208-7, 9628469.
51. McManus C, Berman JW, Brett FM, Staunton H, Farrell M, Brosnan CF. MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study. J Neuroimmunol 1998, 86:20-29. 10.1016/S0165-5728(98)00002-2, 9655469.
52. Galimberti D, Venturelli E, Villa C, Fenoglio C, Clerici F, Marcone A, Benussi L, Cortini F, Scalabrini D, Perini L, et al. MCP-1 A-2518 G polymorphism: effect on susceptibility for frontotemporal lobar degeneration and on cerebrospinal fluid MCP-1 levels. J Alzheimers Dis 2009, 17:125-133.
53. Glabinski AR, Balasingam V, Tani M, Kunkel SL, Strieter RM, Yong VW, Ransohoff RM. Chemokine monocyte chemoattractant protein-1 is expressed by astrocytes after mechanical injury to the brain. J Immunol 1996, 156:4363-4368.
54. Muessel MJ, Berman NE, Klein RM. Early and specific expression of monocyte chemoattractant protein-1 in the thalamus induced by cotrical injury. Brain Res 2000, 870:211-221. 10.1016/S0006-8993(00)02450-1, 10869521.
55. Rutar M, Natoli R, Valter K, Provis JM. Early focal expression of the chemokine Ccl2 by Müller cells during exposure to damage-inducing bright continuous light. Invest Ophthalmol Vis Sci 2011, 52(5):2379-2388. 10.1167/iovs.10-6010, 3081230, 21228381.
56. Rutar M, Provis JM, Valter K. Brief exposure to damaging light causes focal recruitment of macrophages, and long-term destabilization of photoreceptors in the albino rat retina. Curr Eye Res 2010, 35:631-643. 10.3109/02713681003682925, 20597649.
57. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411:494-498. 10.1038/35078107, 11373684.
58. Ameres SL, Martinez J, Schroeder R. Molecular basis for target RNA recognition and cleavage by human RISC. Cell 2007, 130:101-112. 10.1016/j.cell.2007.04.037, 17632058.
59. Gao H, Pennesi M, Shah K, Qiao X, Hariprasad SM, Mieler WF, Wu SM, Holz ER. Safety of intravitreal voriconazole: electroretinographic and histopathologic studies. Trans Am Ophthalmol Soc 2003, 101:183-189. discussion 189, 1358987, 14971576.
60. Natoli R, Provis J, Valter K, Stone J. Gene regulation induced in the C57BL/6 J mouse retina by hyperoxia: a temporal microarray study. Mol Vis 2008, 14:1983-1994. 2579940, 18989387.
61. Cornish EE, Madigan MC, Natoli R, Hales A, Hendrickson AE, Provis JM. Gradients of cone differentiation and FGF expression during development of the foveal depression in macaque retina. Vis Neurosci 2005, 22:447-459.
62. Maslim J, Valter K, Egensperger R, et al. Tissue oxygen during a critical developmental period controls the death and survival of photoreceptors. Invest Ophthalmol Vis Sci 1997, 38:1667-1677.
63. Ng TF, Streilein JW. Light-induced migration of retinal microglia into the subretinal space. Invest Ophthalmol Vis Sci 2001, 42:3301-3310.
64. Chen L, Yang P, Kijlsta A. Distribution, markers, and functions of retinal microglia. Ocul Immunol Inflamm 2002, 10:27-39. 10.1076/ocii.10.1.27.10328, 12461701.
65. Davoust N, Vuaillat C, Androdias G, Nataf S. From bone marrow to microglia: barriers and avenues. Trends Immunol 2008, 29:227-234. 10.1016/j.it.2008.01.010, 18396103.
66. Joly S, Francke M, Ulbricht E, Beck S, Seeliger M, Hirrlinger P, Hirrlinger J, Lang KS, Zinkernagel M, Odermatt B, et al. Cooperative phagocytes: resident microglia and bone marrow immigrants remove dead photoreceptors in retinal lesions. Am J Pathol 2009, 174:2310-2323. 10.2353/ajpath.2009.090023, 2684195, 19435787.
67. Zhang C, Shen JK, Lam TT, Zeng HY, Chiang SK, Yang F, Tso MO. Activation of microglia and chemokines in light-induced retinal degeneration. Mol Vis 2005, 11:887-895.
68. Shi G, Maminishkis A, Banzon T, Jalickee S, Li R, Hammer J, Miller SS. Control of chemokine gradients by the retinal pigment epithelium. Invest Ophthalmol Vis Sci 2008, 49:4620-4630. 10.1167/iovs.08-1816, 2574653, 18450597.
69. Elner SG, Elner VM, Bian ZM, Lukacs NW, Kurtz RM, Strieter RM, Kunkel SL. Human retinal pigment epithelial cell interleukin-8 and monocyte chemotactic protein-1 modulation by T-lymphocyte products. Invest Ophthalmol Vis Sci 1997, 38:446-455.
70. Elner VM, Burnstine MA, Strieter RM, Kunkel SL, Elner SG. Cell-associated human retinal pigment epithelium interleukin-8 and monocyte chemotactic protein-1: immunochemical and in-situ hybridization analyses. Exp Eye Res 1997, 65:781-789. 10.1006/exer.1997.0380, 9441701.
71. Bian ZM, Elner SG, Strieter RM, Kunkel SL, Lukacs NW, Elner VM. IL-4 potentiates IL-1beta- and TNF-alpha-stimulated IL-8 and MCP-1 protein production in human retinal pigment epithelial cells. Curr Eye Res 1999, 18:349-357. 10.1076/ceyr.18.5.349.5353, 10372996.
72. Holtkamp GM, Kijlstra A, Peek R, de Vos AF. Retinal pigment epithelium-immune system interactions: cytokine production and cytokine-induced changes. Prog Retin Eye Res 2001, 20:29-48. 10.1016/S1350-9462(00)00017-3, 11070367.
73. Kaneko H, Nishiguchi KM, Nakamura M, Kachi S, Terasaki H. Characteristics of bone marrow-derived microglia in the normal and injured retina. Invest Ophthalmol Vis Sci 2008, 49:4162-4168. 10.1167/iovs.08-1738, 18487364.
74. Yoshimura T, Leonard EJ. Identification of high affinity receptors for human monocyte chemoattractant protein-1 on human monocytes. J Immunol 1990, 145:292-297.
75. Zhang J, Shi XQ, Echeverry S, Mogil JS, De Koninck Y, Rivest S. Expression of CCR2 in both resident and bone marrow-derived microglia plays a critical role in neuropathic pain. J Neurosci 2007, 27:12396-12406. 10.1523/JNEUROSCI.3016-07.2007, 17989304.
76. Yang D, Elner SG, Chen X, Field MG, Petty HR, Elner VM. MCP-1-activated monocytes induce apoptosis in human retinal pigment epithelium. Invest Ophthalmol Vis Sci 2011, 52:6026-6034. 10.1167/iovs.10-7023, 3176077, 21447688.
77. Elner VM, Elner SG, Standiford TJ, Lukacs NW, Strieter RM, Kunkel SL. Interleukin-7 (IL-7) induces retinal pigment epithelial cell MCP-1 and IL-8. Exp Eye Res 1996, 63:297-303. 10.1006/exer.1996.0118, 8943702.
78. Palframan RT, Jung S, Cheng G, Weninger W, Luo Y, Dorf M, Littman DR, Rollins BJ, Zweerink H, Rot A, von Andrian UH. Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues. J Exp Med 2001, 194:1361-1373. 10.1084/jem.194.9.1361, 2195988, 11696600.
79. Lu B, Rutledge BJ, Gu L, Fiorillo J, Lukacs NW, Kunkel SL, North R, Gerard C, Rollins BJ. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med 1998, 187:601-608. 10.1084/jem.187.4.601, 2212142, 9463410.
80. Huang DR, Wang J, Kivisakk P, Rollins BJ, Ransohoff RM. Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J Exp Med 2001, 193:713-726. 10.1084/jem.193.6.713, 2193420, 11257138.
81. Thompson WL, Karpus WJ, Van Eldik LJ. MCP-1-deficient mice show reduced neuroinflammatory responses and increased peripheral inflammatory responses to peripheral endotoxin insult. J Neuroinflammation 2008, 5:35. 10.1186/1742-2094-5-35, 2527558, 18706086.
82. Joly S, Samardzija M, Wenzel A, Thiersch M, Grimm C. Nonessential role of beta3 and beta5 integrin subunits for efficient clearance of cellular debris after light-induced photoreceptor degeneration. Invest Ophthalmol Vis Sci 2009, 50:1423-1432.
83. Organisciak DT, Vaughan DK. Retinal light damage: mechanisms and protection. Prog Retin Eye Res 2009, 29:113-134. 2831109, 19951742.
84. Wenzel A, Grimm C, Samardzija M, Remé CE. Molecular mechanisms of light induced photoreceptor apoptosis and neuroprotection for retinal degeneration. Prog Ret Eye Res 2005, 24:275-306.
85. Sullivan R, Penfold P, Pow DV. Neuronal migration and glial remodeling in degenerating retinas of aged rats and in nonneovascular AMD. Invest Ophthalmol Vis Sci 2003, 44:856-865. 10.1167/iovs.02-0416, 12556422.
86. Marco-Gomariz MA, Hurtado-Montalban N, Vidal-Sanz M, Lund RD, Villegas-Perez MP. Phototoxic-induced photoreceptor degeneration causes retinal ganglion cell degeneration in pigmented rats. J Comp Neurol 2006, 498:163-179. 10.1002/cne.21028, 16856141.
87. Marc RE, Jones BW, Watt CB, Vazquez-Chona F, Vaughan DK, Organisciak DT. Extreme retinal remodeling triggered by light damage: implications for age related macular degeneration. Mol Vis 2008, 14:782-806. 2375357, 18483561.
88. Rapaport DH, Stone J. The area centralis of the retina in the cat and other mammals: focal point for function and development of the visual system. Neuroscience 1984, 11:289-301. 10.1016/0306-4522(84)90024-1, 6425714.
89. Fukuda Y. A three-group classification of rat retinal ganglion cells: histological and physiological studies. Brain Res 1977, 119:327-344. 10.1016/0006-8993(77)90314-6, 830390.
90. Rowe MH, Dreher B. Functional morphology of beta cells in the area centralis of the cat's retina: a model for the evolution of central retinal specializations. Brain Behav Evol 1982, 21:1-23.
91. Espinosa-Heidmann DG, Suner IJ, Hernandez EP, Monroy D, Csaky KG, Cousins SW. Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 2003, 44:3586-3592. 10.1167/iovs.03-0038, 12882811.
92. Combadiere C, Feumi C, Raoul W, Keller N, Rodero M, Pezard A, Lavalette S, Houssier M, Jonet L, Picard E, et al. CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. J Clin Invest 2007, 117:2920-2928. 10.1172/JCI31692, 1994614, 17909628.
93. Sakurai E, Anand A, Ambati BK, van Rooijen N, Ambati J. Macrophage depletion inhibits experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 2003, 44:3578-3585. 10.1167/iovs.03-0097, 12882810.
94. Newman AM, Gallo NB, Hancox LS, Miller NJ, Radeke CM, Maloney MA, Cooper JB, Hageman GS, Anderson DH, Johnson LV, Radeke MJ. Systems-level analysis of age-related macular degeneration reveals global biomarkers and phenotype-specific functional networks. Genome Med 2012, 4:16. 10.1186/gm315, 3372225, 22364233.
95. Kramer M, Hasanreisoglu M, Feldman A, Siegel RA, Sonis P, Maharshak I, Monselise Y, Gurevich M, Weinberger D. Monocyte chemoattractant protein-1 in the aqueous humor of patients with age-related macular degeneration. Clin Experiment Ophthalmol 2012, 40:617-12. 10.1111/j.1442-9071.2011.02747.x, 22172228.
96. Jonas JB, Tao Y, Neumaier M, Findeisen P. Monocyte chemoattractant protein 1, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1 in exudative age-related macular degeneration. Arch Ophthalmol 2010, 128:1281-1286. 10.1001/archophthalmol.2010.227, 20937997.
97. Chen M, Muckersie E, Forrester JV, Xu H. Immune activation in retinal aging: a gene expression study. Invest Ophthalmol Vis Sci 2010, 51:5888-5896. 10.1167/iovs.09-5103, 20538981.
98. Luhmann UF, Robbie S, Munro PM, Barker SE, Duran Y, Luong V, Fitzke FW, Bainbridge JW, Ali RR, MacLaren RE. The drusenlike phenotype in aging Ccl2-knockout mice is caused by an accelerated accumulation of swollen autofluorescent subretinal macrophages. Invest Ophthalmol Vis Sci 2009, 50:5934-5943. 10.1167/iovs.09-3462, 2801148, 19578022.
99. Tsutsumi C, Sonoda KH, Egashira K, Qiao H, Hisatomi T, Nakao S, Ishibashi M, Charo IF, Sakamoto T, Murata T, Ishibashi T. The critical role of ocular-infiltrating macrophages in the development of choroidal neovascularization. J Leukoc Biol 2003, 74:25-32. 10.1189/jlb.0902436, 12832439.
100. Ambati J, Anand A, Fernandez S, Sakurai E, Lynn BC, Kuziel WA, Rollins BJ, Ambati BK. An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat Med 2003, 9:1390-1397. 10.1038/nm950, 14566334.
101. Raoul W, Auvynet C, Camelo S, Guillonneau X, Feumi C, Combadiere C, Sennlaub F. CCL2/CCR2 and CX3CL1/CX3CR1 chemokine axes and their possible involvement in age-related macular degeneration. J Neuroinflammation 2010, 7:87. 10.1186/1742-2094-7-87, 3003653, 21126357.
102. Soutschek J, Akinc A, Bramlage B, Charisse K, Constien R, Donoghue M, Elbashir S, Geick A, Hadwiger P, Harborth J, et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 2004, 432:173-178. 10.1038/nature03121, 15538359.
103. Whitehead KA, Langer R, Anderson DG. Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov 2009, 8:129-138. 10.1038/nrd2742, 19180106.
104. Shen J, Samul R, Silva RL, Akiyama H, Liu H, Saishin Y, Hackett SF, Zinnen S, Kossen K, Fosnaugh K, et al. Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1. Gene Ther 2006, 13:225-234. 10.1038/sj.gt.3302641, 16195704.
105. Reich SJ, Fosnot J, Kuroki A, Tang W, Yang X, Maguire AM, Bennett J, Tolentino MJ. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model. Mol Vis 2003, 9:210-216.
106. Kleinman ME, Yamada K, Takeda A, Chandrasekaran V, Nozaki M, Baffi JZ, Albuquerque RJ, Yamasaki S, Itaya M, Pan Y, et al. Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature 2008, 452:591-597. 10.1038/nature06765, 2642938, 18368052.